Chronic Lymphocytic Leukemia
Jennifer Brown, MD, PhD
Optimizing the Use of B-Cell Signaling Inhibitors in CLL #BeyondASH21
More from Chronic Lymphocytic Leukemia
Beyond the Congress Panel Discussion CLL #BeyondASH21
Susan O'Brien, MD
; Recently Presented Data of Clinical Trials in Patients with CLL #BeyondASH21
Nitin Jain, MD
Best Strategies for Incorporating Novel Agents, Combinations, and Sequencing of Agents/Regimens in the R/R Setting #BeyondASH21
